Silvercrest Asset Management Group LLC Sells 43,608 Shares of Integer Holdings Co. (NYSE:ITGR)

Silvercrest Asset Management Group LLC cut its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 5.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 771,119 shares of the medical equipment provider's stock after selling 43,608 shares during the quarter. Silvercrest Asset Management Group LLC owned about 2.30% of Integer worth $102,189,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. increased its position in Integer by 4.4% in the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock valued at $220,000 after buying an additional 71 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Integer by 0.9% during the fourth quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock valued at $1,290,000 after acquiring an additional 84 shares in the last quarter. HighPoint Advisor Group LLC raised its position in shares of Integer by 6.4% during the fourth quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 101 shares during the period. Norden Group LLC raised its position in shares of Integer by 7.0% during the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock worth $221,000 after purchasing an additional 109 shares during the period. Finally, Corient Private Wealth LLC lifted its holdings in shares of Integer by 6.4% in the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock worth $261,000 after purchasing an additional 118 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

ITGR traded down $2.94 during trading on Wednesday, hitting $118.65. 106,858 shares of the company traded hands, compared to its average volume of 369,135. The firm has a market cap of $4.14 billion, a P/E ratio of 35.43, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36. The stock's fifty day moving average is $118.41 and its 200 day moving average is $129.42.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. During the same quarter last year, the business posted $1.14 EPS. Integer's quarterly revenue was up 7.3% compared to the same quarter last year. As a group, equities analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ITGR. KeyCorp dropped their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Benchmark lowered their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Raymond James upped their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Finally, StockNews.com upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus price target of $145.56.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.16% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.